Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis.

[1]  A. Ramzy,et al.  Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: a systematic review and meta-analysis , 2020, Open Heart.

[2]  H. Jneid,et al.  Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer , 2020, Journal of the American Heart Association.

[3]  I. Grumbach.  Cardio‐Oncology at the Beginning of a New Decade , 2020, Journal of the American Heart Association.

[4]  J. Kirkpatrick,et al.  Palliative cardiovascular care: The right patient at the right time , 2019, Clinical cardiology.

[5]  Peter Y. Kim,et al.  The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis? , 2019, Current Cardiology Reports.

[6]  G. Schuler,et al.  Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement , 2018, Journal of interventional cardiology.

[7]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[8]  Jeroen J. Bax,et al.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines , 2016, European journal of heart failure.

[9]  V. Falk,et al.  Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology ( ESC ) and the European Association for CardioThoracic Surgery ( EACTS ) , 2017 .

[10]  G. Lip,et al.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). , 2016, European heart journal.

[11]  K. Takagi,et al.  Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer. , 2016, The American journal of cardiology.

[12]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[13]  Hongyan Qiao,et al.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. , 2015, Journal of the American College of Cardiology.

[14]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[15]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[16]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[17]  Sung-Bae Kim,et al.  Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. , 2013, The Lancet. Oncology.

[18]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[19]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[20]  F. Rosenfeldt,et al.  Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. , 2012, Heart, lung & circulation.

[21]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[22]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[23]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[24]  J. Durand,et al.  Management and outcomes of severe aortic stenosis in cancer patients. , 2011, American heart journal.

[25]  I. Palacios,et al.  Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: Immediate, short‐ and long‐term outcome at 2 years , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[26]  G. Deeb,et al.  Unoperated patients with severe aortic stenosis. , 2007, Journal of the American College of Cardiology.

[27]  R. Morris,et al.  Open heart surgery in patients with chronic lymphocytic leukemia. , 1999, Leukemia research.

[28]  K S Pieper,et al.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. , 1995, Journal of the American College of Cardiology.